Allied Market Research
Loading...
0
New
New
2021
Hematology Analyzer Market

Hematology Analyzer Market by Product & Service (Instruments, Reagent & Consumables, and Services), Type (Fully-Automated Hematology Analyzer and Semi-Automated Hematology Analyzer), and End User (Hospitals, Clinical Laboratories, Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.

A13630
Pages: 261
Sep 2021 | 270 Views
   
Author(s) : Apoorva Srivastava , Onkar Sumant
Tables: 128
Charts: 49
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Hematology Analyzer Market

Request Now !

Hematology Analyzer Market Overview:

The global hematology analyzer market size was valued at $1,962.40 million in 2020 and is projected to reach $3,941.10 million by 2030 registering a CAGR of 7.30% from 2021 to 2030. Hematology analyzers are computerized, highly specialized machines that count the number of different types of red and white blood cells, blood platelets, hemoglobin, and hematocrit levels in a blood sample. They include programmable automated alarm systems for indicating results outside the reference range. Hematology analyzers are concerned with detection, monitoring of diseases, prognosis and subsequent screening and are extensively used against various blood related diseases such as hemophilia, blood cancer and blood clots. Other diseases include leukemia, anemia, blood transfusion, malignant lymphomas, and others where hematology diagnosis is used.

The COVID-19 pandemic has helped the industry grow significantly, as the demand for hematology analyzer increased owing to increase in focus on the hematology parameters for the assessment of COVID-19 around the world. This supports the hematology analyzer market to gain traction during the forecast period.

Rise in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, is a major factor that drives the growth of the market. In addition, technological advancements in hematology analyzers, and growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer further fuel the growth of the hematology analyzer market. However, high cost of hematology analyzers owing to advanced features and automation may hinder the growth of the market. Furthermore, stringent regulatory policies for hematology analyzers are also expected to limit the growth of the market. In contrast, growth opportunities in emerging economics expected to offer lucrative opportunities for players in the hematology analyzer market.

Hematology-Analyzer-Market

Get more information on this report : Request Sample Pages

The outbreak of COVID-19 has disrupted workflows in the health care sector around the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of health care. However, there is positive effect on the hematology analyzer market owing to increase in focus on the hematology parameters for the assessment of COVID-19 around the world. Several studies are carried out in research institutions, and many of the hospitals started using the hematology analyzers to test and monitor COVID-19 patients without spreading the virus. For the practical and efficient screening of the large populations for the COVID-19 infection, some research studies from China recommended including white blood cells (WBC) and C-reactive protein (CRP) in laboratory examinations for early monitoring of infection. On March 18, 2020, Sight announced that Israel’s government-run Sheba Tel Hashomer Hospital is using its OLO, the first blood count device for point-of-care to conduct CBC tests to monitor and treat its COVID-19 patients to mitigate the risk of contamination.

hematology analyzer market segmentation 

The global hematology analyzer market is segmented on the basis of product & service, type, end user, and region to provide a detailed assessment of the market. By product & service, it is classified into instruments, reagent & consumables, and services. By type, it is segmented into fully-automated hematology analyzer and semi-automated hematology analyzer. Based on end user, it is categorized into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment Review

Based on product & service, the hematology analyzer market is segmented into instruments, reagent & consumables, and services. Reagent & consumables segment dominated the global market in 2020 and is expected to remain dominant throughout the forecast period owing to factors such as increase in adoption of reagent and consumables in clinical laboratories for blood cell counts, coagulation testing, other hematology tests, control, and calibration.

Hematology Analyzer Market
By Product & Services

Your browser does not support the canvas element.

Reagents & Consumables segment holds a dominant position in 2020 and would continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Based on type, it is segmented into fully-automated hematology analyzer and semi-automated hematology analyzer. Fully-automated hematology analyzer segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. This is attributed to growing preference for automated hematology instruments, along with increasing technological advancements, and the combination of basic flow-cytometry techniques in automated hematology analyzers.

Based on end user, it is classified into hospitals, clinical laboratories, research institutes, and others. Other segment includes blood banks, and biopharma companies. Clinical laboratories segment held the largest share in 2020 and is expected to remain dominant throughout the forecast period owing to presence of high-quality equipment in clinical laboratories and the accurate results obtained from them. Furthermore, convenience and accurate results in clinical laboratories are the two major reasons driving the growth of the segment during the forecast period.

Hematology Analyzer Market
By Type

Your browser does not support the canvas element.

Fully automated hematology analyzer segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

Snapshot of the Asia-Pacific hematology analyzer market 

Asia-Pacific offers profitable opportunities for key players operating in the hematology analyzer market, thereby registering the fastest growth rate during the forecast period, owing to growing healthcare infrastructure, increasing prevalence of blood diseases, rising disposable incomes, well-established presence of domestic companies, and aging population in the region. In addition, factors such as increase in population and growth in the economies of developing countries such as India and China, are also supporting the growth of the hematology analyzer market in Asia. Technological advancements coupled with supportive investments and funds by the government, especially in developing countries, such as India and China, are also expected to contribute to market growth.

Hematology Analyzer Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

North America is expected to experience growth at the highest rate, registering a CAGR of 6.20 % during the forecast period.

Get more information on this report : Request Sample Pages

The key market players profiled in the report include Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc.), Bio-Rad Laboratories, Boule Diagnostics AB, F Hoffmann-La Roche Ltd, Hobira Ltd, Nihon Kohden Corporation, Siemens Healthineers, Stratec SE (Diatron MI Plc.), and Sysmex Corporation.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the global hematology analyzer market along with the current trends and future estimations to explain the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the hematology analyzer market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing hematology analyzer market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of hematology analyzer used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the hematology analyzer market.

Key Market Segments

By Product & Service

  • Instruments
  • Reagents & Consumables
  • Services

By Type

  • Fully-Automated Hematology Analyzers
  • Semi-automated Hematology Analyzers

By End User

  • Hospitals
  • Clinical Laboratories
  • Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA  
 

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in prevalence of blood disorders
3.5.1.2.Technological advancements in hematology analyzers
3.5.1.3.Growth in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer

3.5.2.Restraints

3.5.2.1.High cost of hematology analyzers
3.5.2.2.Stringent regulatory policies for hematology analyzers

3.5.3.Opportunities

3.5.3.1.Growth opportunities in emerging economics

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on the hematology analyzer market

CHAPTER 4:HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICE

4.1.Overview

4.1.1.Market size and forecast

4.2.Instruments

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast for instruments, by end user
4.2.3.Market analysis, by country

4.3.Reagents and consumables

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.2.1.Market size and forecast for reagents & consumables, by end user
4.3.3.Market analysis, by country

4.4.Services

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast

4.4.2.1.Market size and forecast for services, by end user

4.4.3.Market analysis, by country

CHAPTER 5:HEMATOLOGY ANALYZER MARKET, BY TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Fully Automated Hematology Analyzer

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Semi-Automated Hematology Analyzer

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:HEMATOLOGY ANALYZER MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Clinical Laboratories

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Research Institutes

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

6.5.Others

6.5.1.Market size and forecast
6.5.2.Market analysis, by country

CHAPTER 7:HEMATOLOGY ANALYZER MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. hematology analyzer market, by product & services
7.2.2.1.2.U.S. hematology analyzer market, by type
7.2.2.1.3.U.S. hematology analyzer market, by end user

7.2.2.2.Canada

7.2.2.2.1.Canada hematology analyzer market, by product & services
7.2.2.2.2.Canada hematology analyzer market, by type
7.2.2.2.3.Canada hematology analyzer market, by end user

7.2.2.3.Mexico

7.2.2.3.1.Mexico hematology analyzer market, by product & services
7.2.2.3.2.Mexico hematology analyzer market, by type
7.2.2.3.3.Mexico hematology analyzer market, by end user

7.2.3.North America market size and forecast, by product & services
7.2.4.North America market size and forecast, by type
7.2.5.North America market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany hematology analyzer market, by product & services
7.3.2.1.2.Germany hematology analyzer market, by type
7.3.2.1.3.Germany hematology analyzer market, by end user

7.3.2.2.France

7.3.2.2.1.France hematology analyzer market, by product & services
7.3.2.2.2.France hematology analyzer market, by type
7.3.2.2.3.France hematology analyzer market, by end user

7.3.2.3.UK

7.3.2.3.1.UK hematology analyzer market, by product & services
7.3.2.3.2.UK hematology analyzer market, by type
7.3.2.3.3.UK hematology analyzer market, by end user

7.3.2.4.Italy

7.3.2.4.1.Italy hematology analyzer market, by product & services
7.3.2.4.2.Italy hematology analyzer market, by type
7.3.2.4.3.Italy hematology analyzer market, by end user

7.3.2.5.Spain

7.3.2.5.1.Spain hematology analyzer market, by product & services
7.3.2.5.2.Spain hematology analyzer market, by type
7.3.2.5.3.Spain hematology analyzer market, by end user

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe hematology analyzer market, by product & services
7.3.2.6.2.Rest of Europe hematology analyzer market, by type
7.3.2.6.3.Rest of Europe hematology analyzer market, by end user

7.3.3.Europe market size and forecast, by product & services
7.3.4.Europe market size and forecast, by type
7.3.5.Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan hematology analyzer market, by product & services
7.4.2.1.2.Japan hematology analyzer market, by type
7.4.2.1.3.Japan hematology analyzer market, by end user

7.4.2.2.China

7.4.2.2.1.China hematology analyzer market, by product & services
7.4.2.2.2.China hematology analyzer market, by type
7.4.2.2.3.China hematology analyzer market, by end user

7.4.2.3.Australia

7.4.2.3.1.Australia hematology analyzer market, by product & services
7.4.2.3.2.Australia hematology analyzer market, by type
7.4.2.3.3.Australia hematology analyzer market, by end user

7.4.2.4.India

7.4.2.4.1.India hematology analyzer market, by product & services
7.4.2.4.2.India hematology analyzer market, by type
7.4.2.4.3.India hematology analyzer market, by end user

7.4.2.5.South Korea

7.4.2.5.1.South Korea hematology analyzer market, by Product & services
7.4.2.5.2.South Korea hematology analyzer market, by type
7.4.2.5.3.South Korea hematology analyzer market, by end user

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific hematology analyzer market, by product & services
7.4.2.6.2.Rest of Asia-Pacific hematology analyzer market, by type
7.4.2.6.3.Rest of Asia-Pacific hematology analyzer market, by end user

7.4.3.Asia-Pacific market size and forecast, by product & services
7.4.4.Asia-Pacific market size and forecast, by type
7.4.5.Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil hematology analyzer market, by product & services
7.5.2.1.2.Brazil hematology analyzer market, by type
7.5.2.1.3.Brazil hematology analyzer market, by end user

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia hematology analyzer market, by product & services
7.5.2.2.2.Saudi Arabia hematology analyzer market, by type
7.5.2.2.3.Saudi Arabia hematology analyzer market, by end user

7.5.2.3.South Africa

7.5.2.3.1.South Africa hematology analyzer market, by product & services
7.5.2.3.2.South Africa hematology analyzer market, by type
7.5.2.3.3.South Africa hematology analyzer market, by end user

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA hematology analyzer market, by product & services
7.5.2.4.2.Rest of LAMEA hematology analyzer market, by type
7.5.2.4.3.Rest of LAMEA hematology analyzer market, by end user

7.5.3.LAMEA market size and forecast, by product & services
7.5.4.LAMEA market size and forecast, by type
7.5.5.LAMEA market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.ABBOTT LABORATORIES

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.BIO-RAD LABORATORIES, INC.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance

8.3.BOULE DIAGNOSTICS AB

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments

8.4.DANAHER CORPORATION (BECKMAN COULTER INC.)

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments

8.5.F. HOFFMANN-LA ROCHE AG

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.HORIBA, LTD.

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.6.6.Key strategic moves and developments

8.7.NIHON KOHDEN CORPORATION

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.SIEMENS AG

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.STRATEC SE (DIATRON MI PLC)

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.SYSMEX CORPORATION

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.GLOBAL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 02.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY REGION, 2020-2030($MILLION)
TABLE 03.HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY END USER, 2020-2030($MILLION)
TABLE 04.HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020-2030($MILLION)
TABLE 05.HEMATOLOGY ANALYZER MARKET FOR REAGENTS & CONSUMABLES, BY END USER, 2020-2030($MILLION)
TABLE 06.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY REGION, 2020-2030($MILLION)
TABLE 07.HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY END USER, 2020-2030($MILLION)
TABLE 08.GLOBAL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 09.HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 10.HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 12.HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)
TABLE 13.HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 14.HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020-2030($MILLION)
TABLE 15.HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY REGION, 2020-2030($MILLION)
TABLE 16.HEMATOLOGY ANALYZER MARKET, BY REGION, 2020-2030($MILLION)
TABLE 17.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 18.U.S. HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 19.U.S. HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 20.U.S. HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 21.CANADA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 22.CANADA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 23.CANADA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 24.MEXICO HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 25.MEXICO HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 26.MEXICO HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 27.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 28.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 29.NORTH AMERICA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 30.EUROPE HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 31.GERMANY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 32.GERMANY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 33.GERMANY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 34.FRANCE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 35.FRANCE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 36.FRANCE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 37.UK HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 38.UK HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 39.UK HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 40.ITALY HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 41.ITALY HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 42.ITALY HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 43.SPAIN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 44.SPAIN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 45.SPAIN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 46.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 47.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 48.REST OF EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 49.EUROPE HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 50.EUROPE HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 51.EUROPE HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 52.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 53.JAPAN HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 54.JAPAN HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 55.JAPAN HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 56.CHINA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 57.CHINA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 58.CHINA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 59.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 60.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 61.AUSTRALIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 62.INDIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 63.INDIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 64.INDIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 65.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 66.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 67.SOUTH KOREA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 68.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 69.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 70.REST OF ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 71.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 72.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 73.ASIA-PACIFIC HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 74.LAMEA HEMATOLOGY ANALYZER MARKET, BY COUNTRY, 2020-2030($MILLION)
TABLE 75.BRAZIL HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 76.BRAZIL HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 77.BRAZIL HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 78.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 79.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 80.SAUDI ARABIA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 81.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 82.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 83.SOUTH AFRICA HEMATOLOGY ANALYZER MARKET, BY END USER 2020-2030($MILLION)
TABLE 84.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 85.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 86.REST OF LAMEA HEMATOLOGY ANALYZER MARKET, END USER, 2020-2030($MILLION)
TABLE 87.LAMEA HEMATOLOGY ANALYZER MARKET, BY PRODUCT & SERVICES, 2020-2030($MILLION)
TABLE 88.LAMEA HEMATOLOGY ANALYZER MARKET, BY TYPE, 2020-2030($MILLION)
TABLE 89.LAMEA HEMATOLOGY ANALYZER MARKET, BY END USER, 2020-2030($MILLION)
TABLE 90.ABBOTT: COMPANY SNAPSHOT
TABLE 91.ABBOTT: OPERATING SEGMENTS
TABLE 92.ABBOTT: PRODUCT PORTFOLIO
TABLE 93.ABBOTT: KEY DEVELOPMENTS
TABLE 94.BIORAD: COMPANY SNAPSHOT
TABLE 95.BIORAD: OPERATING SEGMENTS
TABLE 96.BIORAD: PRODUCT PORTFOLIO
TABLE 97.BOULE: COMPANY SNAPSHOT
TABLE 98.BOULE: OPERATING SEGMENTS
TABLE 99.BOULE: PRODUCT PORTFOLIO
TABLE 100.BOULE: KEY DEVELOPMENTS
TABLE 101.DANAHER: COMPANY SNAPSHOT
TABLE 102.DANAHER: OPERATING SEGMENTS
TABLE 103.DANAHER: PRODUCT PORTFOLIO
TABLE 104.DANAHER: KEY DEVELOPMENTS
TABLE 105.ROCHE: COMPANY SNAPSHOT
TABLE 106.ROCHE: OPEARING SEGMENTS
TABLE 107.ROCHE: PRODUCT PORTFOLIO
TABLE 108.ROCHE: KEY DEVELOPMENTS
TABLE 109.HORIBA: COMPANY SNAPSHOT
TABLE 110.HORIBA: OPERATING SEGMENTS
TABLE 111.HORIBA: PRODUCT PORTFOLIO
TABLE 112.HORIBA: KEY DEVELOPMENTS
TABLE 113.NIHON: COMPANY SNAPSHOT
TABLE 114.NIHON: OPERATING SEGMENTS
TABLE 115.NIHON: PRODUCT PORTFOLIO
TABLE 116.NIHON: KEY DEVELOPMENTS
TABLE 117.SIEMENS: COMPANY SNAPSHOT
TABLE 118.SIEMENS: OPERATING SEGMENTS
TABLE 119.SIEMENS: PRODUCT PORTFOLIO
TABLE 120.SIEMENS: KEY DEVELOPMENTS
TABLE 121.STRATEC: COMPANY SNAPSHOT
TABLE 122.STRATEC: OPERATING SEGMENTS
TABLE 123.STRATEC: PRODUCT PORTFOLIO
TABLE 124.STRATEC: KEY DEVELOPMENTS
TABLE 125.SYSMEX: COMPANY SNAPSHOT
TABLE 126.SYSMEX: OPERATING SEGMENTS
TABLE 127.SYSMEX: PRODUCT PORTFOLIO
TABLE 128.SIEMENS: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 01.HEMATOLOGY ANALYZER MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.HIGH INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR INSTRUMENTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS HEMATOLOGY ANALYZER MARKET FOR FULLY AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR SEMI-AUTOMATED HEMATOLOGY ANALYZER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF HEMATOLOGY ANALYZER MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 25.BIORAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.BIORAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 27.BIORAD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 28.BOULE: NET SALES, 2018–2020 ($MILLION)
FIGURE 29.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 30.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 32.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.ROCHE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 35.HORIBA: NET SALES, 2018–2020 ($MILLION)
FIGURE 36.HORIBA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.HORIBA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.NIHON: NET SALES, 2019–2021 ($MILLION)
FIGURE 39.NIHON: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 40.NIHON: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 41.SIEMENS: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.SIEMENS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 44.STRATEC: NET SALES, 2018–2020 ($MILLION)
FIGURE 45.STRATEC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 46.STRATEC: REVENUE SHARE BY REGION, 2020(%)
FIGURE 47.SYSMEX: NET SALES, 2018–2020 ($MILLION)
FIGURE 48.SYSMEX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 49.SYSMEX: REVENUE SHARE BY REGION, 2020(%)

 
 

Hematology analyzers are computerized, highly specialized and automated machines that count the number of different kinds of white and red blood cells in a blood sample. The results they provide are collectively known as complete blood counts (CBCs) or complete blood count with differentiation of cells.

Rise in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, technological advancements in hematology analyzers, and increase in demand for automated hematology analyzer coupled with rising preference toward high sensitivity hematology analyzer are some factors that boost growth of the market. Furthermore, growth opportunities in emerging economics owing to growing awareness regarding better health care facilities, rising occurrences of diseases and increasing population in emerging countries, are expected to create lucrative opportunity for market growth. However, high cost of hematology analyzers and stringent regulatory policies for hematology analyzers are some factors that are expected to hinder growth of the market. 

The reagent & consumable segment is expected to remain dominant during the forecast period, owing to increase in adoption of reagent and consumables in clinical laboratories for blood cell counts, coagulation testing, other hematology tests, control, and calibration. Moreover, North America is expected to offer lucrative opportunities to the market during the forecast period, due to increase in cases of patients suffering from blood disorders, the rise in prevalence of target diseases, and surge in demand for blood transfusions in the region.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. Hematology analyzers are computerized, highly specialized and automated machines that count the number of different kinds of white and red blood cells in a blood sample.

A. Hematology analyzers are used in the diagnosis and treatment of a wide range of diseases related to red blood cells, white blood cells, platelets, blood vessels, bone marrow, lymph nodes, spleen, and the proteins involved in bleeding and clotting.

A. The total market value of hematology analyzer market is $1962.40 million in 2020.

A. The base year is 2020 in hematology analyzer market

A. Top companies such asSiemens Healthineers, Abbott Laboratories, F Hoffmann-La Roche Ltd, Danaher Corporation (Beckman Coulter Inc.) and Sysmex Corporation held a high market position in 2020.

A. Reagents & consumables segment is the most influencing segment owing to increase in adoption of reagent and consumables in clinical laboratories for blood cell counts, coagulation testing, other hematology tests, control, and calibration.

A. Rise in prevalence of blood disorders such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, technological advancements in hematology analyzers, and increase in demand for automated hematology analyzer coupled with rising preference towards high sensitivity hematology analyzer are some factors which boost growth of the market

A. Asia-Pacific is expected to experience the highest growth rate during the forecast period, owing to growing healthcare infrastructure, increasing prevalence of blood diseases, rising disposable incomes, well-established presence of domestic companies, and aging population in the region.

A. The forcast period for hematology analyzer market is 2021 to 2030

A. The market value of hematology analyzer market in 2021 is $2087.20 million.

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Hematology Analyzer Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers